Literature DB >> 1506363

Influence of human muscle length on energy transduction studied by 31P-NMR.

A J Baker1, P J Carson, A T Green, R G Miller, M W Weiner.   

Abstract

Muscle contractions at lengths below the optimum for force development were previously found to cause less fatigue than contractions at the optimum length (Lo). Decreased fatigability was suggested to arise from fewer cross-bridge interactions in shortened sarcomeres. In the present study, this suggestion was tested by monitoring energy use of human ankle dorsiflexor muscles during and after contractions at Lo and shortened lengths (Ls) with phosphorus nuclear magnetic resonance spectroscopy. The nuclear magnetic resonance spectra indicated similar rates of ATP use during contractions at Lo and Ls. Phosphocreatine, at an initial concentration of 37 mM, was reduced to an equivalent extent by 2 min of ischemic exercise at Lo (to 2.3 mM) and Ls (to 4.7 mM). Changes in pH (indicating glycolytic ATP production) were also equivalent at Lo and Ls. Exercise caused pH to fall from an initial level of 7.07 to 6.5 at Lo and to 6.53 at Ls. In relation to previous experiments performed under similar conditions on human ankle dorsiflexor muscles, the present experiments suggest that in shortened muscle the decreased force found in this and previous studies and the decreased fatigability that was previously found may not be simply due to fewer cross-bridge interactions in shortened sarcomeres. Examination of the relationships between developed force and levels of metabolites suggests that changes of force during fatigue and recovery correlate better with intracellular [Pi] and H2PO4- than with [H+].

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1506363     DOI: 10.1152/jappl.1992.73.1.160

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  9 in total

Review 1.  Is fatigue all in your head? A critical review of the central governor model.

Authors:  J P Weir; T W Beck; J T Cramer; T J Housh
Journal:  Br J Sports Med       Date:  2006-07       Impact factor: 13.800

2.  Knee angle-dependent oxygen consumption of human quadriceps muscles during maximal voluntary and electrically evoked contractions.

Authors:  R D Kooistra; C J de Ruiter; A de Haan
Journal:  Eur J Appl Physiol       Date:  2007-10-26       Impact factor: 3.078

3.  Frequent alternate muscle activity of plantar flexor synergists and muscle endurance during low-level static contractions as a function of ankle position.

Authors:  Hiroyuki Tamaki; Hikari Kirimoto; Kengo Yotani; Hiroaki Takekura
Journal:  J Physiol Sci       Date:  2011-06-09       Impact factor: 2.781

4.  Recovery of power output and muscle metabolites following 30 s of maximal sprint cycling in man.

Authors:  G C Bogdanis; M E Nevill; L H Boobis; H K Lakomy; A M Nevill
Journal:  J Physiol       Date:  1995-01-15       Impact factor: 5.182

5.  The effects of joint angle on electromyographic indices of fatigue.

Authors:  J P Weir; A L McDonough; V J Hill
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

6.  Knee extensor muscle oxygen consumption in relation to muscle activation.

Authors:  R D Kooistra; M E Blaauboer; J R Born; C J de Ruiter; A de Haan
Journal:  Eur J Appl Physiol       Date:  2006-11-07       Impact factor: 3.078

7.  Impact of length during repetitive contractions on fatigue in rat skeletal muscle.

Authors:  Meredith B MacNaughton; Brian R MacIntosh
Journal:  Pflugers Arch       Date:  2007-05-01       Impact factor: 3.657

8.  Diminished fatigue at reduced muscle length in human skeletal muscle.

Authors:  Samuel C K Lee; Anthony Braim; Cara N Becker; Laura A Prosser; Ann M Tokay; Stuart A Binder-Macleod
Journal:  Muscle Nerve       Date:  2007-12       Impact factor: 3.217

9.  Concentric strength training at optimal or short muscle length improves strength equally but does not reduce fatigability of hamstring muscles.

Authors:  Katja K Pedersen; Martin K Madsen; Lars G Hvid; Kristian Overgaard
Journal:  Physiol Rep       Date:  2019-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.